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Abstract 
 
The synthesis of unbridged biscarbene iridium(I) [Ir(cod)(MeIm∩Z)2]+ complexes 
having N- or O-functionalized NHC ligands (∩Z = 2-methoxybenzyl, pyridin-2-
ylmethyl and quinolin-8-ylmethyl) is described. The molecular structures of the 
complexes show an antiparallel disposition of the carbene ligands that minimize the 
steric repulsions between the bulky substituents. However, the complexes were found to 
be dynamic in solution due to the restricted rotation about the C(carbene)-Ir bond that 
results in two interconverting diasteromers having different disposition of the 
functionalized NHC ligands. A rotational barrier of around 80 kJ mol-1 (298 K) has been 
determined by 2D EXSY NMR spectroscopy. The iridium(III) dihydride complex 
[IrH2(MeIm∩Z)2]+ (∩Z = pyridin-2-ylmethyl) has been prepared by reaction of the 
corresponding iridium(I) complex with molecular hydrogen. These complexes 
efficiently catalyzed the transfer hydrogenation of cyclohexanone using 2-propanol as 
hydrogen source and KOH as base at 80 °C with average TOFs of 117-155 h-1 at 0.1 
mol% iridium catalyst loading. All the catalyst precursors showed comparable activity 
independent both of the wingtip type at the NHC ligands or the counterion. Mechanistic 
studies support the involvement of diene free bis-NHC iridium(I) intermediates in these 
catalytic systems. DFT calculations have shown that a MPV-like concerted mechanism 
(Meerwein-Ponndorf-Verley mechanism), involving the direct hydrogen transfer at the 
coordination sphere of the iridium center, might compete with the well-established 
hydrido mechanism. Indirect evidence of a MPV-like mechanism has been found for the 
catalyst precursor having NHC ligands having with a pyridin-2-ylmethyl wingtip. 
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Introduction 
Heteroditopic ligands of hemilabile character have attracted much attention in recent 
years due to their potential for catalyst design by tuning the coordination sphere of the 
metal center. It is well known that functionalized ligands, such as phosphine and N-
heterocyclic carbenes (NHCs), with labile bonding groups can play a dual role in a 
catalyst since they can easily enable coordinative sites at the metal center and, at the 
same time, protect the coordination sites by a dynamic “on and off” chelating effect.1 In 
particular, functionalized NHC ligands have the advantageous property of combining 
the strong electron-donor ability of the carbene moiety, which form a strong bond to 
metal centers, with the lability of the donor function that allows for the stabilization of 
transient intermediates in organometallic catalysts.2,3 In this context, a large number of 
complexes containing functionalized NHC ligands have been synthesized and the 
hemilabile character of several NHC ligands having O, N or S- donor functions has 
been demonstrated.4 Interestingly, the active role of the hemilabile fragment has been 
identified in several catalytic processes.5 
NHC ligands have been increasingly used in the design of hydrogen transfer 
catalysts.6 It has been found that, in contrast to phosphine-based catalysts, iridium-NHC 
complexes are more active than their Rh-NHC analogues and accordingly, a number of 
highly efficient neutral and cationic NHC iridium catalysts have been recently reported.7 
reported.7 In particular, air-stable Ir(III) NHC-based complexes were found to be active 
catalysts for transfer hydrogenation of ketones, aldehydes, and imines at low catalyst 
loading.8 It has been evidenced that the catalyst efficiency in transfer hydrogenation of 
ketones by sterically demanding unsymmetrically N,N’-substituted benzimidazol-2-
ylidene [IrBr(cod)(NHC)] complexes was improved when using NHC ligands having a 
2-methoxyethyl substituent.9 In the same way, highly effective iridium(I) hydrogen 
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transfer catalysts based on unsymmetrical 2-methoxyphenyl donor-functionalized 
expanded ring NHCs have been recently reported.10 Thus, it becomes evident that the 
presence of a hemilabile fragment on the catalyst structure has a considerable impact on 
hydrogen transfer catalytic activity. 
Late transition metal catalyzed transfer hydrogenation of unsaturated substrates has 
been explained through different mechanisms involving both monohydride or dihydride 
species, according to an inner-sphere mechanism, or concerning the participation of a 
ligand in the catalytic reaction, according to an outer sphere metal-ligand bifunctional 
catalysis mechanism.11 However, in the case of Ir(I) complexes, the monohydride 
mechanism seems to be preferred.12 Mechanistic studies on cationic complexes having a 
methoxy-functionalized NHC ligand (NHC∩Z, type I, Chart 1), in combination with 
DFT calculations, allowed us to disclose that the interaction of the MeO- fragment of 
the NHC ligand with an alcoxo intermediates species facilitates the β-H elimination step 
in route to the key hydrido [IrH(cod)(NHC∩Z)] intermediate species.13 On the other 
hand, bridged bis-NHC ligands have proven to be very useful for the tuning of the 
electronic and steric properties of the metal centers. [M(bis-NHC)(OAc)I2]8f (type II, 
Chart 1) and [M(cod)(bis-NHC)]+,14 (type III, Chart 1) complexes, having M(III) and 
M(I) metal centers (M = Rh, Ir), respectively, have also been shown to be efficient 
catalysts for transfer hydrogenation although no mechanistic investigations have been 
performed so far. In contrast, the catalytic activity of unbridged biscarbene 
[M(cod)(NHC)2]+ complexes in hydrogen transfer reactions remains unexplored. 
The aim of this work is to synthesize iridium(I) [Ir(cod)(NHC∩Z)2]+ complexes 
having two N- or O-functionalized NHC ligands (type IV, Chart 1) in order to evaluate 
their catalytic activity in transfer hydrogenation of ketones. The presence of two 
uncoordinated donor functions in these catalyst precursors should facilitate the 
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stabilization of coordinatively unsaturated catalytic intermediates. In addition, from a 
mechanistic point of view, a direct hydrogen transfer mechanism where the hydrogen 
transfer takes place between an alkoxide ligand and a ketone simultaneously 
coordinated to the iridium center, Meerwein-Ponndorf-Verley mechanism (MPV), could 
be operative in these systems due to the presence of two strongly bonded NHC ligands. 
In fact, computational studies have given support to the MPV mechanism for some 
iridium catalysts.15 
 
 
Chart 1. Mono- and bis-NHC metal complexes as hydrogen transfer catalysts (M = Rh, 
Ir). 
 
 
 
Results and Discussion 
Synthesis of Precursors for Hemilabile NHC Ligands. The imidazolium salt 
precursors for selected O- and N-donor rigid functionalized N-heterocyclic carbene 
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ligands (Chart 2) were prepared by alkylation of 1-methylimidazole with the 
corresponding functionalized alkyl bromide. The salt 1-(2-methoxybenzyl)-3-methyl-
1H-imidazol-3-ium bromide (1)13 was synthesized by alkylation of 1-methylimidazole 
with 2-methoxybenzyl bromide, prepared by bromination of 2-methoxybenzyl 
alcohol,16 in toluene following the procedure described for the N-tert-butyl derivative.17 
In the same way, 1-(pyridin-2-ylmethyl)-3-methyl-1H-imidazol-3-ium bromide (2) was 
prepared using 2-(bromomethyl)pyridine as alkylating reagent.18 1-(Quinolin-8-
ylmethyl)-3-methyl-1H-imidazol-3-ium hexafluorophosphate (3) was prepared 
following the procedure described by Webster and Li.19  
 
 
Chart 2. Imidazolium salt precursors for functionalized NHC ligands. 
Unbridged bis-carbene [M(cod)(NHC)2]+ complexes are accessible by several specific 
synthetic methods, as for example, the double NHC transfer under halide abstraction 
using [Ag(NHC)2]NTf220 or imidazolium-2-carboxylate adducts (NHC-CO2)21 as 
transmetalation agents. However, the use of alkoxo ligands or external alkoxide bases as 
deprotonating agents of the imidazolium salts,22,23,24 has proved to be especially useful 
for the preparation of the target iridium(I) [Ir(cod)(NHC∩Z)2]+ complexes. In contrast, 
the use of silver [(NHC∩Z)AgX]n25 complexes as transmetalation agents resulted in the 
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formation of complex mixtures that contain the neutral [IrX(cod)(NHC∩Z)] 
compounds. 
Complexes [Ir(cod){MeIm(2-methoxybenzyl)}2]Br (4.Br) and 
[Ir(cod){MeIm(pyridin-2-ylmethyl)}2]Br (5.Br) have been synthesized applying the 
Herrmann’s method slightly modified,22 via deprotonation of the imidazolium salts 1 
and 2 by the bridging ethoxo ligands in the dimer [Ir(µ-OEt)(cod)]2, generated in situ by 
reaction of [Ir(µ-Cl)(cod)]2 with NaH in ethanol, in the presence of an excess of NaOEt 
(Scheme 1). The complexes were obtained as yellow-orange microcrystalline solids in 
good yield after extraction with dichloromethane and crystallization with n-hexane. The 
corresponding hexafluorophosphate salts, 4.PF6 and 5.PF6, were prepared by metathesis 
of the bromide salts with NaPF6 in dichloromethane. The application of the Herrmann’s 
methodology to the bromide salt of the quinolin-8-ylmethyl imidazolium derivative 
resulted in the formation of 6.Br in low yield. However, the in situ deprotonation of the 
hexafluophosphate imidazolium salt 3 by the strong base KOtBu, and further reaction 
with [Ir(µ-Cl)(cod)]2 directly afforded [Ir(cod){MeIm(quinolin-8-ylmethyl)}2]PF6 
(6.PF6), which was isolated as an orange microcrystalline solid in 80% yield. 
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Scheme 1. General method for the preparation of [Ir(cod)(NHC∩Z)2]+ (NHC∩Z = 
functionalized NHC ligand) complexes 4−6+. 
The iridium(I) [Ir(cod)(NHC∩Z)2]X (∩Z = 2-methoxybenzyl, 4; pyridin-2-ylmethyl, 
5; quinolin-8-ylmethyl, 6; X = Br or PF6) complexes have been fully characterized by 
elemental analysis, mass spectrometry and multinuclear NMR spectroscopy. The 
MALDI-Tof mass spectra showed the molecular ions with the correct isotopic 
distribution and in some cases those derived of the loss of the cod and/or NHC∩Z 
ligands. Conductivity measurements of solutions of the complexes in acetone agreed 
with the presence of 1:1 electrolytes. In addition, the IR spectra of complexes 4-6.PF6 
showed a broad strong band corresponding to the stretching vibrations of the PF6- anion 
(840 cm-1), and the characteristic septet resonance for the PF6- anion was observed in 
the 31P{1H} NMR spectra at around δ -144 ppm.  
The 1H and 13C{1H} NMR of the complexes exhibited duplicated resonances for both 
cod and NHC ligands, which evidenced the presence of two symmetrical isomers (see 
Supporting Information). The NMR spectroscopic data are in agreement with the 
existence of two diasteromers for these complexes derived from the relative disposition 
of the functionalized NHC ligands: the up-down isomer (C2 symmetry) and the up-up 
isomer (Cs symmetry) having antiparallel and parallel arrangement of the carbene 
ligands, respectively (Figure 1). 
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Figure 1. Equilibrium between the two diasteromers of complexes 
[Ir(cod)(MeIm∩Z)2]+ (4+–6+).  
 
Reliable assignment for the 1H and 13C{1H} resonances of both diasteromers was 
achieved by combination of the 1H-1H COSY, 13C APT and 1H-13C HSQC spectra. 
Interestingly, the bidimensional 1H-1H-NOESY spectra of the complexes show strong 
exchange cross-peaks between all types of protons for both species, together with weak 
NOE cross-peaks, indicating that both diasteromers interconvert in solution (Figure 1). 
As can be seen in the selected region of the 1H-1H NOESY NMR spectrum of 5.Br in 
CD2Cl2 at 300 K (Figure 2) exchange cross-peaks between the >CH2 and -Me 
resonances of the 1-(pyridin-2-ylmethyl)-3-methyl-imidazol-2-carbene ligands and the 
=CH resonances of the cod ligands for both isomers are apparent. The bidimensional 
spectrum also allows for the univocally identification of the diasteromers. Thus, the 
major isomer shows proximity NOE cross-peaks between the proton H6 of the pyridine 
wingtip and the methyl protons of the NHC∩Z ligands, which is in agreement with the 
antiparallel arrangement of both ligands in the up-down isomer 5a+. As expected, this 
cross-peak is not observed for the minor isomer 5b+ having parallel NHC∩Z ligands. 
(Figure 2 and Supporting Information).  
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The diasteromer ratio 4a+/4b+ in CD2Cl2 is close to that found in acetone-d6, 1.38 and 
1.22, respectively, at the same temperature (298 K). However, the ratio for 5+ is 
strongly influenced by the solvent. The up-down diastereomer is more abundant in 
CD2Cl2, 5a+/5b+ ratio of 2.3, than in acetone-d6, where a ratio of 1.2 was measured. 
Finally, 6a+/6b+ ratios of 1.86 and 1.42 were found in CDCl3 and CD2Cl2, respectively. 
 
 
 
 
Figure 2. Sections of 2D 1H-1H-NOESY (CD2Cl2, 300 K) NMR spectrum for complex 
5.Br. 
 
Kinetic studies. The interconversion between the up-down and up-up diasteromers of 
complexes 4+-6+ requires the rotation of the NHC∩Z ligands about the Ir-C bond and 
thus, both can be considered as atropisomers. Experimental rotational rates for 5.Br 
were obtained from magnetization transfer experiments using 2D EXSY NMR 
spectroscopy. This method has been increasingly applied to the study of dynamic 
processes, determination of rotational barriers and conformational analysis.26 The basis 
of a quantitative 2D EXSY experiment is the relationship between the intensity of the 
exchange cross-peaks and the rate constants for chemical exchange. The forward and 
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backward exchange rate constants, k1 and k-1, for the equilibrium 5a+  5b+ were 
determined by integration of the cross-peaks between the methyl resonances of the 1-
(pyridin-2-ylmethyl)-3-methyl-imidazol-2-ylidene ligands in both interconverting 
species in the 1H 2D-EXSY NMR spectra. The kinetic parameters for the equilibrium 
5a+  5b+ at four different temperatures are summarized in Table 1. 
The temperature influence on the exchange reaction rate was investigated in the 
temperature range 300-330 K in CD2Cl2 and the activation parameters determined by 
linear least-squares fit using the logarithmic form of the Eyring equation. The kinetic 
parameters obtained from the Eyring plot were ∆H1# = 74.8 ± 4.1 kJmol-1 and ∆S1# = -
11 ± 13 JK-1mol-1, and ∆H-1# = 77.0 ± 4.2 kJmol-1 and ∆S-1# = -11 ± 13 JK-1mol-1 (see 
Supporting Information). Noteworthy, the value close to zero of the entropy term is in 
agreement with an intramolecular interconversion process. The activation barriers for 
the forward (∆G1#) and reverse (∆G-1#) processes were ∆G1# = 78 ± 8 kJmol-1 and ∆G-1# 
=
 80 ± 8 kJmol-1, respectively (298.15 K). 
On the other hand, the calculated equilibrium constants, K, obtained from the 
determined rate constants (KEXSY = k1/k-1) are in good agreement with the experimental 
values, KINT, obtained from the same sample by integration of both methyl resonances in 
an experiment recorded with the same relaxation time. The estimated equilibrium 
constant KINT ranges only between 2.36–2.10 in the temperature range under study. 
Interestingly, the lnK vs 1/T plot gave a linear fit leading to the following 
thermodynamic parameters: ∆Ho = -3.4 kJmol-1 and ∆So = -4.0 Jmol-1 (See Supporting 
Information).  
The rotational barriers of ca. 80 kJmol-1 found in complex 5+ are higher than those 
found in some [RhX(diene)(NHC)] complexes which are in the range 65–70 kJmol-
1
.
27,28
 Evidence for the steric origin of the bond rotation barrier has been recognized,29 
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and in fact, hindered C(carbene)-Rh rotation at room temperature has been observed 
both in complexes [RhX(diene)(NHC)] and [Rh(cod)(NHC)2]+ having NHC ligands 
with bulky substituents.23,30 The dynamic behavior exhibited by our complexes is 
certainly unexpected due to the presence of two bulky functionalized NHC∩Z ligands 
that should hinder the rotation about the Ir-C bond. Likely the rotational process 
involves the concerted motion of both NHC ligands with assistance of the cod ligand or 
the NHC wingtip. 
Table 1. 1H 2D EXSY-derived rate constants (k1 and k-1/s-1) and calculated 
equilibrium constants (K) for the equilibrium 5a+  5b+.a 
 
T (K) k1 (s-1)b k-1 (s-1)b KEXSY c KINT c 
300 0.16 0.07 2.29 2.36 
310 0.45 0.21 2.14 2.29 
320 1.19 0.57 2.11 2.19 
330 2.66 1.26 2.10 2.10 
a
 2D-EXSY NMR spectra (500 MHz) were recorded using a concentrate solution of 5+ 
in CD2Cl2 with an optimized mixing time of 500 ms. b The integrals for the exchange 
cross-peak were processed using the EXSYCalc program to obtain the rate constants k1 
and k
-1. c KEXSY, calculated equilibrium constants from EXSY determined rate constants 
(k1/k-1); KINT, experimental equilibrium constants obtained from the integration of the 
methyl resonances in the 1H NMR spectra. 
 
Structural studies. The structure of the cationic complexes 4+–6+ was also confirmed 
by X-ray analysis on single crystals obtained by slow diffusion of diethyl ether into a 
concentrated solution of the complexes in acetone. The molecular structures of the 
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4.PF6, 5.Br and 6.PF6 salts have been determined, and a view of the corresponding 
cations is depicted in Figure 3. The most representative bond lengths and angles are 
collected in Table 2. 
The asymmetric unit of 5+ includes two crystallographically independent but 
chemically identical molecules. Both of them, together with those of complexes 4+ and 
6+, share several common structural features, in particular, the antiparallel disposition of 
both NHC∩Z ligands, i.e. the up-down diasteromer. In all of them, the metal atom is 
coordinated to the carbon atoms of two NHC∩Z ligands and to the two olefinic bonds 
of a cyclooctadiene molecule, in a slightly distorted square-planar environment. 
Coordination angles formed by the carbenic carbon atoms and the centroid of the 
diolefines are close to 90°. Deviations from this magnitude are found in the bite angle of 
cod ligands, whose values are close to the mean value found in Ir(cod) fragments in 
mononuclear square-planar complexes (85.9(10)º).31 The presence of the olefin places 
the NHC ligands in a relative cis position, contrary to the preferred trans disposition 
observed in iridium complexes with two symmetrical monodentate NHC ligands where 
Ccarbene-Ir-Ccarbene angles bigger than 160º are found.32 The C(9)-Ir-C(12) angles are also 
slightly different from 90º, with a mean value of 94.19(2)º, and the two carbene 
heterocycles are nearly perpendicular, as reported in [Ir(cod)(NHC)2]20 and 
[Ir(cod)(MeImPz)2]24 (Pz = pyrazolyl) complexes. These features, together with the up-
down disposition of the carbene ligands, minimize the steric repulsions between the 
bulkiest substituents on the NHC∩Z carbene ligands, which are located as far away as 
possible. The Ir-Ccarbene bond distances, in the range 2.045(3)-2.078(12) Å, were found 
to be similar to those of Ir(I)-(NHC)2 complexes as well as related iridium(I)-NHC 
complexes containing substituents in the carbene ligand with possible hemilabile 
characteristics.20,23a,24,33 
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Dihedral angles between the planes of the NHC∩Z carbene ligands and the metal 
coordination mean plane measured in these structures are of 80.5(4)º and 78.1(4)º for 
complex 4+; 71.9(2), 77.2(2), 77.4(2) and 75.9(2)º for 5+; and 81.47(9) and 82.57(10)º 
for 6+. These values agree with those observed in [RhCl(ICy)2(PPh3)] (ICy = 1,3-
dicyclohexylimidazol-2-ylidene) (78.6 and 79.2º)34 and [Ir(cod)(ICy)2] (78.0 and 
75.3º)22a complexes, where the NHC carbene ligands are relatively trans- and cis- 
located, respectively. Considering Ir and Rh complexes having bidentate methylene-
bridged bis-NHC ligands it is noteworthy that the dihedral angles γ found in complexes 
4+, 5+ and 6+ are larger than those reported in complexes with one >CH2 bridge 8f,25,35,36 
but similar to those with longer chains ((CH2)n; n = 3 or 4). 22a,37  
 
                   4+     5+    6 +             
Figure 3. View of the cations of complexes 4.PF6, 5.Br and 6.PF6. Hydrogen atoms 
have been omitted for clarity. 
Table 2. Selected bond lengths (Å) and angles (º).  
 
    4+                  5+     6+ 
Ir(1)-M(1)ª 2.097(10) 2.086(8) 2.088(7) 2.076(3) 
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Ir(1)-M(2)ª 2.067(16) 2.096(7) 2.079(8) 2.074(3) 
Ir(1)-C(9) 2.078(12) 2.058(7) 2.045(7) 2.045(3) 
Ir(1)-C(12) 2.061(13) 2.062(7) 2.047(6) 2.045(3) 
M(1)-Ir(1)-M(2) 86.0(6) 85.2(3) 86.1(3) 85.94(12) 
M(1)-Ir(1)-C(9) 171.9(5) 171.9(3) 171.3(3) 174.70(11) 
M(1)-Ir(1)-C(12) 89.8(5) 90.7(3) 91.4(3) 90.68(12) 
M(2)-Ir(1)-C(9) 90.6(5) 90.7(3) 89.3(3) 90.23(10) 
M(2)-Ir(1)-C(12) 170.4(6) 170.6(3) 169.6(3) 174.93(10) 
C(9)-Ir(1)-C(12) 94.6(5) 94.4(3) 94.4(3) 93.39(9) 
N(1)-C(9)-N(2) 106.1(10) 103.8(6) 103.5(6) 104.1(2) 
N(3)-C(12)-N(4) 104.9(11) 104.1(6) 103.8(5) 104.1(2) 
 
ª M(1) and M(2) are the midpoints of olefinic C(1)=C(2) and C(5)=C(6) bonds, 
respectively. 
 
Synthesis of [IrH2{κ2C,N-MeIm(pyridin-2-ylmethyl)}2]PF6 (7.PF6). The cationic 
bis-NHC∩Z iridium(I) complexes 4–6+ did not react with molecular hydrogen at room 
temperature. However, under more forcing conditions of pressure and temperature 
reaction was observed in all cases although only complex 5+ gave a clean reaction 
product. Probably the higher coordination ability of the pyridine fragment compared to 
quinoline or methoxy might be responsible of the difference in the reactivity. Reaction 
of 5.PF6 with dihydrogen at 10 bar and 60 °C for 48 hours gave a pale yellow solution 
from which the iridium(III) dihydride complex [IrH2{κ2C,N-MeIm(pyridin-2-
ylmethyl)}2]PF6 (7.PF6) was isolated as a pale yellow solid in 81 % yield. Complex 7+ 
results from the oxidative addition of hydrogen, hydrogenation of the 1,5-
cyclooctadiene ligand and release of cyclooctene, which was detected by GC/MS 
analysis of the reaction mixture (Scheme 2).  
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Scheme 2. Synthesis of [IrH2{κ2C,N-MeIm(pyridin-2-ylmethyl)}2]+ (7+). 
Complex 7+ is conductor in acetone and the MS mass spectra displays the molecular 
ion at m/z of 541.2. The 1H NMR spectrum of 7+ in CD3CN showed the absence of the 
typical resonances of the cod ligand and the presence of two high field doublet 
resonances at δ −9.60 and −20.12 ppm for the two hydrido ligands. The magnitude of 
the JH-H coupling constant of 5.6 Hz is indicative of a mutually cis disposition of both 
hydrido ligands. In addition, the spectra show no equivalent NHC ligands, which is 
consistent with an unsymmetrical structure with the hydrido ligands having very 
different trans ligands. Thus, compound 7+ is an unsymmetrical iridium(III) octahedral 
complex having two 1-(pyridin-2-ylmethyl)-3-methyl-imidazol-2-ylidene ligands κ2-
C,N coordinated (Scheme 2). The sterochemistry of 7+ has been univocally established 
with the help of the two-dimensional 1H-1H-NOESY spectrum of a CD3CN solution of 
7+ due to the presence of proximity cross peaks of the hydrido resonances with protons 
of different fragments of the molecule (Figure 4).  
The hydrido ligand at δ −9.60 ppm presents NOE effect with the H6 proton of 
pyridine fragment of a NHC ligand and with the bridging methylene of the other, which 
suggest that is located trans to the carbenic atom carbon of the first one. In contrast, the 
hydrido ligand at δ −20.12 ppm should be the one located trans to pyridine as it presents 
NOE effect with the methyl substituent of the same NHC ligand and with the bridging 
methylene resonance of the second (Figure 4). The large upfield shift of the hydrido 
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resonance trans to pyridine ligand compared to the one trans to the carbene is in 
agreement with that found for related dihydrido octahedral iridium complexes having an 
abnormal NHC ligand derived from 2-pyridylmethylimidazolium salts.38  
 
Figure 4. 1H-1H-NOESY (CD3CN, 300 K) NMR spectrum of [IrH2{κ2C,N-
MeIm(pyridin-2-ylmethyl)}2]+ (7+).  
Hydrogen Transfer Catalysis by [Ir(cod)(MeIm∩Z)2]X (X = Br, PF6) Complexes. 
The cationic complexes having two N- or O-functionalized NHC ligands, 
[Ir(cod)(MeIm∩Z)2]+ (4+-6+), have been tested as catalysts for transfer hydrogenation of 
cyclohexanone using 2-propanol as hydrogen source and KOH as base. The influence of 
the wingtip fragment of the NHC ligand, 2-methoxybenzyl (4+), pyridin-2-ylmethyl (5+) 
or quinolin-8-ylmethyl (6+), and the counter anion (X = Br- or PF6-), in the catalytic 
activity has been investigated. The obtained results under optimized standard conditions 
for related catalytic systems,13 catalyst/cyclohexanone/base ratio of 1/1000/5 at 80 °C, 
are summarized in Table 3. 
 
Table 3. Hydrogen Transfer from 2-Propanol to Cyclohexanone Catalyzed by 
[Ir(cod)(MeIm∩Z)2]X (X = Br, PF6).a,b  
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entry catalyst time (min) 
conversion 
(%) TON TOF
c/h−1 TOF50d/h−1 
       1 4.Br 480 94 941 118 578 
2 4.PF6 475 92 922 117 588 
3 5.Br 395 93 932 142 887 
4 5.PF6 380 94 943 149 909 
5 6.PF6 420 91 910 130 652 
7 7.PF6 370 95 954 155 462 
 
a Reaction conditions: catalyst/cyclohexanone/base: 1/1000/5, [Ir]0 = 1 x 10-3 M in 2-
propanol at 80 °C. b The reactions were monitored by GC using mesitylene as 
internal standard. c Average turnover frequency (mol of product/mol of catalyst per 
hour) determined at the reaction time. d TOF50 calculated at 50% conversion of 
cyclohexanone. 
 
The cationic [Ir(cod)(MeIm∩Z)2]+ complexes showed a moderate catalytic activity in 
the reduction of cyclohexanone. The required time to reach conversions over 95% is 6-8 
h with average TOFs of 117-155 h-1. As can be seen in Table 3, the counterion (Br- or 
PF6-) has little influence on the catalytic activity (entries 1-2 and 3-4) thereby 
evidencing that the coordinating ability of the bromide anion does not hinder the 
catalytic activity. It is noticeable that the three catalysts show comparable activity 
independent of the wingtip type at the NHC ligands which contrast with that observed 
for iridium(I) complexes having only one NHC∩Z ligand. In fact, we have shown that 
complexes having O-functionalized NHC ligands provide much more active systems 
than the corresponding N-functionalized ligands.13 In this series, complex 5+ having 
NHC ligands with a pyridin-2-ylmethyl wingtip is slightly more active than the rest with 
an average TOF and TOF50 values of 149 and 909 h-1, respectively. 
The reaction profiles for the hydrogen transfer reduction of cyclohexanone catalyzed 
by the cationic complexes 4+-6+ (hexafluorophosphate salts) are shown in Figure 5. 
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Although complex 5+ exhibits a higher activity up to 70% conversions, the kinetic 
profiles are quite similar showing the absence of an induction period for catalyst 
preactivation which is in accordance with the immediate color change observed when 
the catalytic mixture is heated at 80 °C. 
 
 
Figure 5. Reaction profiles for the catalytic transfer hydrogenation of cyclohexanone 
using 0.1 % of iridium catalyst (hexafluorophosphate salts) in 2-propanol at 80 ºC and 
KOH as base. 
In general, iridium(I) complexes having only one functionalized NHC ligand 
exhibited a superior catalytic performance than related bis-NHC complexes. For 
example, the neutral [IrBr(cod){MeIm(2-methoxibenzyl)}] and cationic 
[Ir(NCCH3)(cod){MeIm(2-methoxibenzyl)}]+ complexes, with average TOFs of 824 
and 4622 h-1, respectively, are considerably more active than 4+ (Table 3, entries 1 and 
2). However, 5+ is more active that [IrBr(cod){MeIm(pyridin-2-ylmethyl)}] (31 h-1) and 
shows comparable activity to [Ir(cod){MeIm(pyridin-2-ylmethyl)}]+ (248 h-1, Table 3, 
entries 3 and 4).13 
The dihydride complex [IrH2{κ2C,N-MeIm(pyridin-2-ylmethyl)}2]PF6 (7.PF6) has 
been prepared in order to assess the possible participation of iridium(III) intermediates 
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in the hydrogen transfer reduction of cyclohexanone catalyzed by [Ir(cod)(MeIm∩Z)2]+ 
complexes. Complex 7.PF6 is also an efficient catalyst precursor giving a similar 
average TOF than 5.PF6 (Table 3, entry 7) showing a comparable kinetic profile 
although with a steady increase of the activity after 2 hours.  Thus, it seems reasonable 
to think that under catalytic conditions the active species generated from 7+ is possibly 
the same than the one formed from 5+. This hypothesis requires the release of the 
cyclooctadiene ligand of 5+. In fact, the GC/MS analysis of a catalytic test carried out 
with a substrate/5+ ratio of 100 evidenced the presence of cyclooctene. Furthermore, the 
catalytic activity is completely inhibited in the presence of 1,2-
bis(diphenylphosphine)ethane (dppe) in the reaction media due to the release of 1,5-
cyclooctadiene (GC/MS evidence) and blocking of the accessible coordination sites. 
These observations strongly suggest that the generation of the active species from 
precatalysts 5+ comes from the reduction of 1,5-cyclooctadiene to cyclooctene, likely 
through the hydrido species [IrH(cod)(MeIm∩Z)2], formed by β-H elimination in the 
neutral alkoxo intermediate [Ir(OR)(cod)(MeIm∩Z)2] (∩Z = pyridin-2-ylmethyl). Thus, 
insertion of the C=C double bond of the cyclooctadiene ligand into the Ir-H bond 
followed by protonolysis should give the key species [Ir(OR)(MeIm∩Z)2] (8a) after 
cyclooctene replacement by an alkoxo ligand. Alternatively, ketone insertion into an Ir-
H bond of the dihydrido complex 7+ followed by reductive elimination of the 
corresponding alcohol and incorporation of an alkoxo ligand, also account for the 
formation of species 8a (Figure 6). 
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Figure 6. Reaction pathways leading to the formation of the catalytic active species 
[Ir(OR)(MeIm∩Z)2] (8a, ∩Z = pyridin-2-ylmethyl from 5+ or 7+. 
 
Mechanism of Transfer Hydrogenation Catalysis by [Ir(cod)(MeIm∩Z)2]+ 
Complexes Having Functionalized N-Heterocyclic Carbene ligands: DFT studies. 
In order to explore the possible mechanisms of the hydrogen transfer process by means 
of DFT calculations two different mechanisms have been considered: the formation of a 
hydride intermediate via β-elimination and a MPV-like pathway (Meerwein-Ponndorf-
Verley mechanism), both starting from the hypothesis of an active catalyst free of 
cyclooctadiene. Two vacant coordination sites become available after cyclooctadiene 
elimination as cyclooctene. They could be occupied by an alkoxo or substrate ligands, 
as well as by the donor atom of the N-substituent on one of the carbene ligands resulting 
in species similar to 8a (Figure 6). In order to avoid the conformational freedom of an 
otherwise uncoordinated sidearm, the catalysts have been somewhat simplified. The 
ligand ImMe2 (1,3-dimethyl-imidazol-2-ylidene) has been used as a model of one of the 
two functionalized NHC ligands while the other one has been fully included. In the 
following discussion a similar numbering scheme is used for the two investigated 
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NHC∩Z ligands, and when necessary they are distinguished as na (e.g.: 8a, ∩Z= 
pyridin-2-ylmethyl) or nb (e.g.: 8b, ∩Z = 2-methoxybenzyl), in a particular numbered 
species. 
Starting from precursor 8, in which the two vacant positions are occupied by an 
isoproxide ligand and the donor atom of the N-substituent of the carbene ligand, the 
Figure 7 summarizes the intermediate hydrido complexes devised for a β-elimination 
pathway. In a first step for this mechanism, β-elimination from the isopropoxide ligand 
could lead to a pentacoordinated hydrido complex 9, via TS 8-9, with calculated 
activation energy of 133.5 kJ/mol. The species 9 is not the most stable isomer for this 
complex, as an isomer with a square planar geometry 13 with the sidearm 
uncoordinated is 18.7 kJ/mol more stable (Figure 8). In fact, similar pentacoordinate 
geometry for the complex having a 2-methoxybenzyl substituent has not been found. 
According to this, a β-elimination pathway with opening of the chelate ring formed by 
the sidearm of the carbene ligand is envisaged. Scanning back the hydrido reinsertion 
process starting from the square planar 13 product sheds some light on the possible 
pathway of the reaction. For this reinsertion process we have found the transition state 
TS 12-13. An IRC analysis shows that this TS connects an agostic intermediate (12a, 
Figure 9, and 12b) with the hydrido species 13a and 13b by very low activation 
energies of 6.6, and 5.9 kJ/mol, respectively (a, ∩Z= pyridin-2-ylmethyl, and b, ∩Z = 
2-methoxybenzyl, Figure 10). The agostic intermediates 12 show a very elongated C-H 
and C=O distances, e.g. 1.227 Å and 1.361 Å for 12a, respectively (Figure 9).39  
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Figure 7. Inner sphere mechanism for the transfer hydrogenation by 
[Ir(cod)(MeIm∩Z)2]+ catalysts involving pentacoordinated monohydride intermediates. 
 
  
 
24 
Figure 8. Catalytic cycle through hydride square-planar intermediates via β-elimination 
from isopropoxide. A route allowing for the coordinating ability of the N-substituent on 
the NHC ligand is depicted (dotted arrows) along with the proposed route (solid 
arrows). The former is discarded due to the higher energies involved and the differences 
which should be experimentally observed for different ligands (see text). 
Accordingly, this route affords an easier pathway to the hydrido intermediates 13a 
and 13b pointing out that opening of the sidearm should be previous to the β-
elimination. This agrees with the mechanistic studies by Hartwig et al.40 that have found 
that a dissociative pathway towards β-elimination in square planar iridium alkoxides 
operates in preference to direct elimination where they propose an structure similar to 
12 as a possible transition state. 
 
Figure 9. Calculated structure for compound 12a and some representative distances for 
the isopropoxide-iridium interaction. 
The acetone ligand in 13 can be replaced by cyclohexanone or by the sidearm 
substitutent on the carbene ligand leading to the square planar hydrido complex 14. 
Formation of this hydrido complex is slightly exergonic (-4.07 kJ/mol) for the 2-
methoxybenzyl complex 14b, but with a net release of energy of 71.1 kJ/mol for the 
pyridin-2-ylmethyl one 14a, what could represent a resting state in the catalytic cycle. 
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Thus, both species 13 and 14 should be in equilibrium. Given the large excess of 
cyclohexanone the concentration of 14 should be low in spite of its stability. After 
replacement of acetone by cyclohexanone (either directly from 13 or through 14) 
intermediate 15 is formed. Then, migratory insertion into the Ir–H bond through TS 15-
16 (with energy barriers of 18.1 kJ/mol for TS 15a-16a, and 12.8 kJ/mol for TS 15b-
16b) results in new alkoxo hydride agostic complexes 16a and 16b. Substitution of the 
formed cyclohexanoxide by isopropoxide in an alcoholysis reaction returns the cycle to 
intermediate 12 rendering cyclohexanol as product, and completing the catalytic cycle 
through hydride square planar intermediates via β-elimination mechanism (Figures 8 
and 10). 
 
 
Figure 10. Energy profiles for the proposed catalytic cycle involving hydrido species. 
The “a” numbered series refer to the catalyst bearing a pyridin-2-ylmethyl 
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functionalized NHC ligand while the “b” series are those referred to the catalyst having 
a NHC with a 2-methoxybenzyl wingtip. 
For a MPV-like mechanism (Figure 11), and also starting from the species 8, the 
opening of the chelate ring formed between the carbene donor and the sidearm can lead 
to the coordination of cyclohexanone rendering the species 17. In that species, the direct 
hydrogen atom transfer from the isopropoxide ligand to the cyclohexanone substrate 
through TS 17-18 (see Figure 12 for TS17a-18a) forms the intermediate 18 from which 
the cyclohexanol product could be directly produced by alcoholysis. In that calculated 
transition state, TS 17-18, the transferred hydrogen sits between both ligands. 
Additionally, this step is energetically feasible as the required activation energies are 
only 31.7 kJ/mol for TS 17a-18a, and 52.3 kJ/mol for TS 17b-18b. The catalytic cycle 
can be closed from the acetone-cyclohexanolate species 18 by substitution of 
cyclohexanoxide by isopropoxide and acetone by cyclohexanone through alcoholysis 
and addition reactions, respectively. 
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Figure 11. Catalytic cycle for a MPV-like concerted mechanism. The dotted arrows 
involve the N-substituent on the carbene ligand and should make a difference in the 
catalytic activity of different ligands. The solid arrows represent the proposed cycle, 
independent on the nature of the substituent on the carbene ligand. 
 
Figure 12. Transition state structure TS17a-18a for a MPV-like concerted mechanism. 
Some relevant distances are shown. 
In light of the above described results, both mechanism pathways seem to be possible. 
The last step, which closes the cycles, could occur through intermediate 8 for both 
ligands and either in a MPV-like mechanism (Figure 11) or through hydrido square 
planar intermediates formed via β-elimination mechanism (Figure 8). Involvement of 
intermediate 8 would lead to very different catalytic activities for the two different N-
substituents (pyridin-2-ylmethyl and 2-methoxybenzyl) given the larger coordination 
ability of pyridine compared to the ether group and the larger stability of the chelate 
ring compared to the one formed with the ether donor, which in both cases should open 
to form the next species in the catalytic cycle. In consequence, if the species 8 were part 
of either a MPV-like mechanism (Figure 11) or an hydride square planar intermediates 
via β-elimination mechanism (Figures 8), the catalytic activity should be significantly 
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lower for complex 5+ than for 4+, as very different energy span would be involved for 
either catalyst (see all the comparative of energies for the different routes in Figure S10 
included in the Supporting Information). On the contrary, our experimental observations 
show that the catalysts [Ir(cod)(MeIm∩Z)2][X] (∩Z = 2-methoxybenzyl, 4+; pyridine-2-
ylmethyl, 5+, quinolin-8-ylmethy, 6+) have all a similar activity which is roughly 
independent on the N-substituent on the carbene ligand (Table 3). Attending to these 
experimental results the species 8 should be outside of both cycles, and the catalytic 
reactions should close by 2-propanol alcoholysis (hydride mechanism, Figure 8) or by 
2-propanol alcoholysis plus substrate addition (MPV-like mechanism, Figure 11). This 
suggests that the substitution processes that close the cycle avoiding intermediate 8 
must be faster than the reorganization process for reforming the chelating ring in the 
presence of a large excess of substrate. In other case, the greater coordinating ability of 
the pyridine substituent should lead to a larger energy span in any of both mechanisms 
compared to the benzylether substituent, which is in disagreement with the experimental 
results.  
The energy span41 for both mechanisms is rather small. For the catalyst containing the 
ligand MeIm(pyridin-2-ylmethyl) an energy span of 18.1 kJ/mol for the hydride 
mechanism and 31.7 kJ/mol for the MPV-like mechanism are found. For the catalyst 
containing the ligand MeIm(2-methoxybenzyl) they amount to 12.8 and 52.3 kJ/mol 
respectively. In the first case (∩Z = pyridin-2-ylmethyl) it is clear that the difference is 
small enough to consider that both mechanisms could operate simultaneously. The case 
where ∩Z = 2-methoxybenzyl deserves some additional comments. The difference of 
ca. 21 kJ/mol in activation energy in the MPV cycle for both catalysts (31.7 vs 52.3 
kJ/mol), although small, is somewhat unexpected. The transition state corresponds to 
the direct transfer of hydrogen form isopropoxide to cyclohexanone and the electronic 
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environment must be similar for both ligands, and the difference must have a steric or 
conformational origin. Lledós, Maseras et al.42 have pointed out that the error 
introduced by conformational diversity can range values of less than 4 kJ/mol to around 
42 kJ/mol. The simplification introduced in one the ligands and the possible 
conformational freedom of the uncoordinated sidearms of the carbene ligands suggest 
that both mechanisms are in a similar range of energy spans and both could be operating 
simultaneously. On the other hand the large excess of cyclohexanone can shift the 
balance to the formation of 17 in the MPV cycle in preference to agostically coordinated 
coordinated 12 in the hydride pathway. 
In order to shed some light on the operating mechanism we have studied the in situ 
generation of the active species under catalytic hydrogen transfer conditions by ESI and 
MALDI- TOF mass spectrometry.13,43 The ESI mass spectrum of a 1x10-3 M solution of 
complex [Ir(cod){MeIm(pyridin-2-ylmethyl)}2]PF6 (5.PF6) in 2-propanol under argon 
atmosphere showed the molecular ion at m/z 647.1 (80%), and the peaks at m/z 539.1 
(34 %) and 471.1 (7%) that correspond to the fragments [Ir(MeIm∩Z)2]+ and 
[Ir(cod)(MeIm∩Z)]+ (∩Z = pyridin-2-ylmethyl), respectively. The ESI mass spectrum 
after addition of a solution of KOH (1:5) and heating at 80 ºC for 15 min showed the 
peak corresponding to [Ir(MeIm∩Z)2]+ although neither the hydrido [IrH(MeIm∩Z)2] 
nor the alocoxo [Ir(OR)(MeIm∩Z)2] intermediates were observed. Both species were 
not observed either in the MALDI-TOF mass spectra, even in linear mode.44 In 
addition, the 1H NMR of a d8-THF solution of 5.PF6 containing KiPrO (1:5) after 
heating at 80 ºC for 30 min did not show any hydrido resonance. Taking into account 
the outstanding stability of the hydrido model intermediate 14, [IrH(ImMe2)(MeIm∩Z)] 
(Figure 8), that might be recognized as the resting state in the hydride mechanism, the 
failure in the identification of the related species [IrH(MeIm∩Z)2] under catalytic 
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conditions, and the small calculated energy span difference between both mechanism 
(ca. 13 kJ/mol) suggest that the transfer hydrogenation by catalyst 5+, based on pyridin-
2-ylmethyl functionalized NHC ligands, could proceed through a MPV-like mechanism. 
 
Conclusions 
Unbridged biscarbene [Ir(cod)(MeIm∩Z)2]+ complexes having functionalized N-
heterocyclic ligands with 2-methoxybenzyl, pyridin-2-ylmethyl and quinolin-8-ylmethyl 
wingtips have been prepared. Restricted rotation about the C(carbene)-Ir bond in these 
complexes results in two interconverting diasteromers derived from the relative 
disposition of the functionalized NHC ligands, up-down and up-up, having antiparallel 
and parallel arrangement of the carbene ligands, respectively. The equilibrium between 
both rotational isomers has been fully characterized by means of 2D-EXSY NMR 
spectroscopy. In the solid state both complexes exhibit an antiparallel disposition of the 
carbene ligands that minimize the steric repulsions between the bulkiest substituents. 
The complexes are efficient catalyst precursor for the transfer hydrogenation of 
cyclohexanone in 2-propanol/KOH exhibiting comparable activity independently both 
of the wingtip type at the NHC ligands and the counterion. Mechanistic studies on the 
formation of the active catalytic species evidenced that the hydrogenation of the 1,5-
cyclooctadiene ligand to cyclooctene is a prerequisite for the generation of key bis-
carbene iridium(I)-alkoxo intermediates. DFT calculations on two possible operating 
mechanisms: the formation of a hydride intermediate via a β-elimination step and a 
direct hydrogen transfer with the metal center acting as Lewis acid (MPV-like concerted 
mechanism), have shown that both mechanism pathways seem to be possible. In the 
catalytic system based on 2-methoxybenzyl functionalized NHC ligands the hydride 
mechanism seems to be favored. However, the model simplification and the possible 
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conformational effects of the uncoordinated wingtip of the NHC ligands suggest a 
similar range of energy spans and then, both mechanisms might be operative. In sharp 
contrast, the small calculated energy span difference between both mechanisms for the 
catalyst based on NHC ligands having a pyridin-2-ylmethyl wingtip, along with the no 
direct observation of a hydrido resting state predicted to be highly stable, suggest that 
hydrogen transfer catalysis could proceed through a MPV-like mechanism. 
 
Experimental Section 
Scientific Equipment. C, H and N analyses were carried out in a Perkin-Elmer 2400 
Series II CHNS/O analyzer. Infrared spectra were recorded on a FT-Perkin-Elmer 
Spectrum One spectrophotometer using Nujol mulls between polyethylene sheets. 1H 
and 13C{1H} NMR spectra were recorded on a Bruker Avance 300 (300.1276 MHz and 
75.4792 MHz) or Bruker Avance 400 (400.1625 MHz and 100.6127 MHz) 
spectrometers. NMR chemical shifts are reported in ppm relative to tetramethylsilane 
and referenced to partially deuterated solvent resonances. Coupling constants (J) are 
given in Hertz. Spectral assignments were achieved by combination of 1H-1H COSY, 
13C APT and 1H-13C HSQC experiments. MALDI-TOF mass spectra were obtained on a 
Bruker MICROFLEX spectrometer using DIT, ditranol, 1,8-dihidroxi-9,10-
dihydroanthracen-9-one, as matrix.45 Electrospray mass spectra (ESI-MS) were 
recorded on a Bruker MicroTof-Q using sodium formiate as reference. Conductivities 
were measured in ca. 5 10-4 M acetone solutions of the complexes using a Philips PW 
9501/01 conductimeter. 
The catalytic reactions were analyzed on an Angilent 4890 D system equipped with 
an HP-INNOWax capillary column (0.4 µm film thickness, 25 m x 0.2 mm i. d.) using 
mesitylene as internal standard. Organic compounds were identified by Gas 
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Chromatography-Mass Spectrometry (GC/MS) using an Agilent 6890 GC system with 
an Agilent 5973 MS detector, equipped with a polar capillary column HP-5MS (0.25 
µm film thickness, 30 m x 0.25 mm i. d.). 
Synthesis. All experiments were carried out under an atmosphere of argon using 
Schlenk techniques. Solvents were distilled immediately prior to use from the 
appropriate drying agents or obtained from a Solvent Purification System (Innovative 
Technologies). Oxygen-free solvents were employed throughout. CDCl3, and CD2Cl2 
were dried using activated molecular sieves, methanol-d4 (<0.02% D2O) was purchased 
from Euriso-top and used as received. MeImH (N-methyl-imidazole) was obtained from 
Sigma-Aldrich and distilled prior to use. The substrates were obtained from common 
commercial sources and used as received, or re-crystallized or distilled prior to use 
depending on their purity. The imidazolium salts [MeImH(2-methoxybenzyl)]Br (1),13 
[MeImH(pyridin-2-ylmethyl)]Br (2),18 and [MeImH(quinolin-8-ylmethyl)]PF6 (3);19 
and the iridium starting materials [Ir(µ-Cl)(cod)]246 and [{Ir(µ-OMe)(cod)}2],47 were 
prepared according to literature procedures.  
General method for the synthesis of complexes [Ir(cod)(MeIm∩Z)2]Br (∩Z = 2-
methoxybenzyl, 4.Br; pyridin-2-ylmethyl, 5.Br). The compounds were prepared 
following the method described by Herrmann.22a To a suspension of [Ir(µ-Cl)(cod)]2 
(0.15 mmol) in ethanol (15 mL) a solution of NaH (1.0 mmol) in ethanol (5 mL) was 
slowly added and stirred at room temperature for 30 min. Then, the corresponding 
imidazolium salt [(MeImH∩Z]Br (0.6 mmol) was added and the suspension stirred for 
72 h. The solvent was pumped off and the residue extracted with CH2Cl2 (3 x 5 mL). 
The solution was concentrated under vacuum to 1mL and then, n-hexane (4 mL) was 
added to give the compounds as orange-yellow solids that were washed with n-hexane 
(3 x 2 mL) and dried under vacuum.  
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[Ir(cod){MeIm(2-methoxybenzyl)}2]Br (4.Br). [Ir(µ-Cl)(cod)]2 (100 mg, 0.149 
mmol), [MeImH(2-methoxybenzyl)]Br (1) (169 mg, 0.596 mmol) and NaH (24.1 mg, 
1.01 mmol). Yield: 81%. Anal. Calcd for C32H40BrN4O2Ir: C, 48.97; H, 5.14; N, 7.14. 
Found: C, 49.08; H, 5.20; N, 7.12. Isomer 4a+: 1H NMR (298 K, acetone-d6): δ 7.35 
(m, 2H, CH Ar), 7.14 (d, J = 2.0, 2H, CH Im), 7.11 (d, J = 7.6, 2H, CH Ar), 7.04 (d, J = 
2.0, 2H, CH Im), 6.85 (m, 2H, CH Ar), 6.62 (dd, J = 7.5, 1.5, 2H, CH Ar), 5.54 (AB 
system, δA = 5.63, δB = 5.43, JAB = 15.0, 4H, NCH2), 4.29 (td, J = 7.8, 2.4, 2H, CH cod), 
4.15 (s, 6H, MeIm), 3.91 (s, 6H, OMe), 3.66 (m, 2H, CH cod), 2.42−2.16 (m, 4H, CH2 
cod), 1.95−1.72 (m, 4H, CH2 cod). 13C{1H} NMR (298K, acetone-d6): δ 178.28 (NCN), 
157.86 (C Ar), 130.35, 128.46 (CH Ar), 125.22 (C Ar), 124.32, 122.43 (CH Im), 
121.44, 111.58 (CH Ar), 78.92, 74.74 (CH cod), 55.99 (OMe), 50.21 (NCH2), 38.17 
(MeIm), 34.06, 29.82 (CH2 cod). Isomer 4b+: 1H NMR (298 K, acetone-d6): δ 7.35 (m, 
2H, CH Ar), 7.33 (d, J = 2.0, 2H, CH Im), 7.11 (d, J = 7.6, 2H, CH Ar), 6.99 (d, J = 2.0, 
2H, CH Im), 6.85 (m, 2H, CH Ar), 6.52 (dd, J = 7.5, 1.5, 2H, CH Ar), 5.39 (AB system, 
δA = 5.82, δB = 4.92, JAB = 15.0, 4H, NCH2), 3.93 (s, 6H, MeIm), 3.98 (m, 2H, CH cod), 
3.90 (s, 6H, OMe), 3.89 (m, 2H, CH cod), 2.42−2.16 (m, 4H, CH2 cod), 1.95−1.72 (m, 
4H, CH2 cod). 13C{1H} NMR (298K, acetone-d6): δ 178.41 (NCN), 157.72 (C Ar), 
130.16, 127.96 (CH Ar), 125.61 (C Ar), 124.27, 122.80 (CH Im), 121.49, 111.52 (CH 
Ar), 76.80, 76.48 (CH cod), 55.95 (OMe), 49.94 (NCH2), 38.83 (MeIm), 31.96, 31.84 
(CH2 cod). MS (MALDI-Tof, CH2Cl2): m/z = 705.3 [M]+. ΛM (acetone): 79 Ω-1 cm2 
mol-1. 
 [Ir(cod){MeIm{pyridin-2-ylmethyl)}2]Br (5.Br). [MeImH(pyridin-2-ylmethyl)]Br 
(2) (100 mg, 0.394 mmol), [Ir(µ-Cl)(cod)]2 (66.1 mg, 0.098 mmol) and NaH (26.5 mg, 
0.663 mmol). Yield: 87%. Anal. Calcd for C28H34BrN6Ir: C, 46.28; H, 4.72; N, 11.56. 
Found: C, 46.37; H, 4.81; N, 11.52. 5a+: 1H NMR (298 K, CD2Cl2): δ 8.47 (d, J = 4.5, 
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2H), 7.63 (td, J = 7.7, 1.7, 2H), 7.25 (m, 2H), 7.06 (d, J = 7.8, 2H) (CH py), 6.95 (d, J = 
1.9, 2H, CH Im), 6.86 (d, J = 1.9, 2H, CH Im), 5.63 (AB system, δA = 5.73, δB = 5.53, 
JAB = 17.5, 4H, NCH2), 4.20 (td, J = 2.2, 7.6, 2H, CH cod), 3.69 (s, 6H, MeIm), 3.57 
(m, 2H, CH cod), 2.31−2.12 (m, 4H, CH2 cod), 1.80 (m, 4H, CH2 cod). 13C{1H} NMR 
(CD2Cl2): δ 178.03 (NCN), 155.33 (C py), 149.59, 137.16, 123.40, 123.09 (CH py), 
122.96, 121.35 (CH Im), 78.97, 74.88 (CH cod), 55.32 (NCH2), 37.47 (MeIm), 33.16, 
29.40 (CH2 cod). 5b+: 1H NMR (298 K, CD2Cl2): δ 8.52 (d, J = 4.5, 2H), 7.69 (td, J = 
7.7, 1.7, 2H), 7.25 (m, 2H) (CH py), 7.18 (d, J = 1.9, 2H, CH Im), 6.99 (d, J = 7.8, 2H, 
CH py), 6.95 (d, J = 1.9, 2H, CH Im), 6.87 (d, J = 1.9, 2H, CH Im), 5.48 (AB system, 
δA = 5.82, δB = 15.0, JAB = 5.2, 4H, NCH2), 4.02 (s, 6H, MeIm), 3.95 (m, 2H, CH cod), 
3.83 (m, 2H, CH cod), 2.31−2.12 (m, 4H, CH2 cod), 2.03 (m, 4H, CH2 cod). 13C{1H} 
NMR (CD2Cl2): δ 177.88 (NCN), 155.30 (C py), 149.86, 137.19 (CH py), 123.45, 
121.80 (CH Im), 121.80, 121.56 (CH py), 76.69, 76.85 (CH cod), 55.17 (NCH2), 38.30 
(MeIm), 31.33, 31.14 (CH2 cod). MS (MALDI-Tof, CH2Cl2): m/z = 647.3 [M]+, 539.2 
[M – C8H12]+. ΛM (acetone): 92 Ω−1 cm2 mol−1. 
Synthesis of [Ir(cod)(MeIm∩Z)2]PF6 (∩Z = 2-methoxybenzyl, 4.PF6; pyridin-2-
ylmethyl, 5.PF6). KPF6 was added to solutions of [Ir(cod){MeIm(2-
methoxybenzyl)}2]Br (4.Br) or [Ir(cod){MeIm{pyridin-2-ylmethyl)}2]Br (5.Br) in 
CH2Cl2 (10 mL) and the mixture stirred for 2 h at room temperature. The inorganic salts 
were removed by filtration and the resulting orange solutions were concentrated under 
vacuum to 1 mL. The addition of Et2O (3 mL) gave the compounds as orange solids that 
were washed with Et2O (3 x 2 mL) and dried in vacuo.  
[Ir(cod){MeIm(2-methoxybenzyl)}2]PF6 (4.PF6). KPF6 (23.5 mg, 0.128 mmol) and 
4.Br (100 mg, 0.128 mmol). Yield: 92%. Anal. Calcd for C32H40F6N4O2PIr: C, 45.22; 
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H, 4.74; N, 6.59. Found: C, 45.34; H, 4.83 N, 6.57. IR (thin film, cm-1): ν(PF6) = 840 
(s). 31P{1H} NMR (acetone-d6): δ -144.26 ppm. 
[Ir(cod){MeIm{pyridin-2-ylmethyl)}2]PF6 (5.PF6). KPF6 (25.3 mg, 0.138 mmol) 
and 5.Br (100 mg, 0.138 mmol). Yield: 91%. Anal. Calcd for C28H34F6N6PIr: C, 42.47; 
H, 4.33; N, 11.61. Found: C, 43.25; H, 4.42; N, 11.64. IR (thin film, cm-1): ν(PF6) = 840 
(s). 31P{1H} NMR (CD2Cl2): δ -144.31 ppm. 
Preparation of [Ir(cod){MeIm{MeIm(quinolin-8-ylmethyl)}2]PF6 (6.PF6). Portions 
of KOtBu (28.3 mg, 0.252 mmol) were added to a stirred suspension of 
[MeImH(quinolin-8-ylmethyl)]PF6 (3) (100 mg, 0.252 mmol) in tetrahydrofurane at 
room temperature. After stirring of the mixture for 30 min, [Ir(µ-Cl)(cod)]2 (42.3 mg, 
0.063 mmol) was added in one portion. The reaction mixture was stirred overnight. 
Removal of the solvent and crystallization from acetone/Et2O at -10 ºC afforded an 
orange microcrystalline solid that was washed with Et2O (3 x 2 mL) and dried under 
vacuum. Yield: 80%. Calculated analysis for C36H38F6IrN6P: C, 48.48; H, 4.29; N, 9.42. 
Found: C, 48.59; H, 4.35; N, 9.44. 6a+: 1H NMR (298 K, CDCl3): δ 8.91 (dd, J = 4.2, 
1.8, 2H), 8.24 (dd, J = 8.3, 1.8, 2H), 7.83 (d, J = 8.2, 2H), 7.52 (dd, J = 8.3, 4.2, 2H), 
7.43 (dd, J = 8.3, 4.2, 2H), 7.36 (m, 2H), 7.03 (m, 2H) (CH quinol), 6.82 (d, J = 1.8, 2H, 
CH Im), 6.80 (d, J = 1.8, 2H, CH Im), 6.09 (AB system, δA = 6.23, δB = 5.95, JAB = 
15.0, 4H, NCH2), 4.42 (t, J = 7.7, 2H, CH cod), 3.64 (s, 6H, MeIm), 3.55 (m, 2H, CH 
cod), 2.1 (m, 4H, CH2 cod), 1.8 (m, 4H, CH2 cod). 13C{1H} NMR (CDCl3): δ 177.76 
(NCN), 150.22 (CH quinol), 145.64 (C quinol), 136.77 (CH quinol), 133.77 (C quinol), 
128.43 (CH quinol), 128.18 (C quinol), 127.54, 126.48 (CH quinol), 123.36, 121.88 
(CH Im), 121.54 (CH quinol), 78.90, 74.24 (CH cod), 50.90 (NCH2), 37.60 (MeIm), 
33.58, 29.36 (CH2 cod). 6b+: 1H NMR (298 K, CDCl3): δ 8.79 (dd, J = 4.1, 1.8, 2H), 
8.13 (dd, J = 8.3, 1.8, 2H), 7.75 (d, J = 8.2, 2H), 7.45 (dd, J = 8.3, 4.2, 2H), 7.36 (m, 
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2H) (CH quinol), 7.11 (d, J = 1.8, 2H, CH Im), 6.73 (m, 2H, CH quinol), 6.67 (d, J = 
1.8, 2H, CH Im), 5.84 (AB system, δA = 6.36, δB = 5.32, JAB = 16.5, 4H, NCH2), 4.11 
(s, 6H, MeIm), 4.03 (m, 2H, CH cod), 3.94 (m, 2H, CH cod), 2.34−2.15 (m, 4H, CH2 
cod), 1.92 (m, 4H, CH2 cod). 13C{1H} NMR (CDCl3): δ 177.93 (NCN), 149.88 (CH 
quinol), 145.57 (C quinol), 136.38 (CH quinol), 134.46, 128.18 (C quinol), 127.98, 
126.70, 126.34 (CH quinol), 123.50, 121.68 (CH Im), 121.54 (CH quinol), 76.54, 76.39 
(CH cod), 50.53 (NCH2), 38.35 (MeIm), 31.54, 31.18 (CH2 cod). 31P{1H} NMR 
(CD2Cl2): δ -144.31 ppm. MS (MALDI-Tof, CH2Cl2): m/z = 747.4 [M]+, 637.6 [M – 
C8H12]+, 524.2 [M – C14H13N3]+. ΛM (acetone): 91 Ω−1cm2mol−1. 
Preparation of [IrH2{κ2C,N-MeIm(pyridin-2-ylmethyl)}2]PF6 (7.PF6). A solution 
of [Ir(cod){MeIm(pyridin-2-ylmethyl)}2]PF6 (5.PF6) (100 mg, 0.140 mmol) in 
acetonitrile (20 mL) was stirred in a Parr reactor at 10 bar of hydrogen pressure and 60 
ºC for 48 h. At the end of this time, the pale yellow solution recovered from the reactor 
was concentrated to 1 mL. Addition of diethyl ether (3 mL) resulted in the formation of 
a yellow solid that was washed with cold diethyl ether (2 x 2 mL) and dried under 
vacuum. Yield: 81%. Anal. Calcd for C20H24F6N6PIr: C, 35.04; H, 3.53; N, 12.26. 
Found: C, 35.11; H, 3.61; N, 12.29. 1H NMR (298 K, CD3CN): δ 8.94 (d, J = 4.2, 1H, 
CH py), 7.92 (m, 3H, CH py), 7.34 (m, 2H, CH Im and CH py), 7.27 (m, 2H, CH Im 
and CH py), 7.14 (m, 1H, CH py), 7.04 (d, J = 2.0, 1H, CH Im), 6.98 (t, J = 7.5, 1H, CH 
py), 6.91 (d, J = 2.0, 1H, CH Im), 5.58 – 5.09 (m, 4H, NCH2), 3.27 (s, 3H, MeIm), 2.22 
(s, 3H, MeIm), −9.66 (d, J = 5.6, 1H, Ir−H), −20.12 (d, J = 5.6, 1H, Ir−H). 13C{1H} 
NMR (298K, CD3CN): δ 174.15, 173.85 (NCN), 155.78, 157.85 (C py), 161.10, 155.09, 
138.93, 138.56, 138.24, 126.18, 125.86 (CH py), 125.54 (CH Im), 122.56 (CH py), 
121.76, 121.65, 120.81 (CH Im), 58.74, 58.43 (NCH2), 37.63, 34.78 (MeIm). 31P{1H} 
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NMR (CD3CN): δ -144.26 ppm. MS (MALDI-Tof, matriz DCTB, CH2Cl2): m/z = 541.2 
[M]+. ΛM (acetone): 91 Ω−1 cm2 mol−1. 
General Procedure for Transfer Hydrogenation Catalysis. The catalytic transfer 
hydrogenation reactions were carried out under an argon atmosphere in thick glass 
reaction tubes fitted with a greaseless high-vacuum stopcock. In a typical experiment, 
the reactor was charged with a solution of the substrate (5 mmol) in 2-propanol (4.5 
mL), internal standard (mesitylene, 70 µL, 0.5 mmol), base (104 µL, 0.025 mmol of a 
KOH solution 0.24 M in 2-propanol) and the catalyst (0.005 mmol, 0.1 mol%). The 
resulting mixture was stirred at room temperature until complete solution of the catalyst 
and then placed in a thermostatized oil bath at the required temperature, typically 80 ºC. 
Conversions were determined by Gas Chromatography analysis under the following 
conditions: column temperature 35 ºC (2 min) to 220 ºC at 10 ºC/min with a flow rate of 
1 mL/min using ultra pure He as carrier gas. 
Determination of the kinetic parameters by 2D-EXSY NMR spectroscopy. The 
kinetic parameters for the equilibrium 5a+  5b+ in 5.Br were obtained from the 1H 2D-
EXSY NMR spectra (500.13 MHz) with a mixing time of 500ms optimized for 300 K 
by using a gradient-selected NOESY program from Bruker (noesygpph). The 
integrations for the exchange cross-peaks between the methyl resonances of the 
functionalized NHC ligands in both diasteromers were processed using the EXSYCalc 
program to compute the rate constants k1 and k-1 (s-1).48 The rotational barriers, ∆G1# and 
∆G
-1
# (kJ·mol-1), were calculated from the chemical exchange-rate constants obtained 
from ESXYCalc, k1 and k-1, using the Eyring equation, k = (kBT/h)exp(-∆G#/RT). The 
activation parameters, ∆H# and ∆S#, were calculated from a linear least-squares fit of 
ln(k/T) vs 1/T. The uncertainties in ∆H# and ∆S# were computed from the error 
propagation formulas derived from the Eyring equation by Girolami and co-workers.49 
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The total uncertainty in the determination of k was assumed to be 5%. The estimated 
uncertainty in the temperature measurements was 1K. 
Calculation details. DFT calculations have been carried out with Gaussian 0950 using 
the B3PW91 functional with a 6-31G** basis set for all atoms but Ir where the 
LANL2DZ basis set and pseudopotential has been used supplemented with an 
additional f function51. All the minima have been characterized by frequency 
calculations. The structures in Figures 9 and 12 have been depicted using CYLview. 
1.0b.52 
Crystal Structure Determination of Complexes [Ir(cod){MeIm(2-
metoxybenzyl)}2]PF6 (4.PF6), [Ir(cod){MeIm(pyridin-2-ylmethyl)}2]Br (5.Br), and 
[Ir(cod){MeIm(quinolin-8-ylmethyl)}2]PF6 (6.PF6). X-ray diffraction data were 
collected at 100(2) K with graphite-monochromated Mo Kα radiation (λ = 0.71073 Å) 
using narrow ω rotation (0.3º) on a Bruker APEX DUO (4.PF6 and 5.Br) or a Bruker 
SMART APEX CCD (6.PF6) diffractometers. Intensities were integrated and corrected 
for absorption effects with SAINT-PLUS and SADABS programs53 included in APEX2 
package. The structures were solved by direct methods with SHELXS-97.54 Refinement 
by full-matrix least-squares on F2, was performed with SHELXL-97.55 Hydrogen atoms 
were included in calculated positions and refined with displacement and positional 
riding parameters. In 4.PF6 and 5.Br complexes, an analysis of the disordered solvent 
region has been performed with SQUEEZE program.56 Particular details concerning 
specific refinement are listed below. 
Crystal data for 4.PF6: C32H40F6IrN4O2P, M = 849.88; orange plate, 0.116 × 0.037 × 
0.030 mm3, triclinic, P 1 , a = 10.946(4), b =11.935(4), c =14.097(5) Å, α = 101.745(7), 
β = 107.631(6), γ = 101.754(7)º; Z =2; V = 1647.4(10) Å3; Dc = 1.713 g/cm3; µ = 4.171 
mm-1; minimum and maximum absorption correction factors: 0.525 and 0.828; 2θmax = 
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42.72º; 9840 collected reflections, 3674 unique (Rint = 0.0747); number of 
data/restraints/parameters 3674/0/419; final GOF 1.010; R1 = 0.0540 (3133 reflections, 
I > 2σ(I)); wR2 = 0.1435 for all data; largest difference peak 2.841 e/Å3. When 
convergence is achieved residual density peaks higher than 1 e/Å3 are found close to the 
iridium atom. They have no chemical sense. Sample crystallizes in tiny plates, mutually 
stuck. Several crystals were tested before selecting the one used for the data collection. 
Most of them have shown to be slightly twinned. Eventually, a very weakly diffracting 
crystal was selected. No detectable intensity was observed over 43º and therefore this 
value has been used as cut-off during the integration process. 
Crystal data for 5.Br: 2(C28H34BrIrN6)·O2H·CH2Cl2, M = 1556.39; orange plate, 
0.099 × 0.082 × 0.043 mm3, triclinic, P 1 , a = 10.390(6), b =14.148(8), c =20.021(11) 
Å, α = 88.505(8), β = 89.648(8), γ = 78.507(8)º; Z =2; V = 2883(3) Å3; Dc = 1.793 
g/cm3; µ = 6.141 mm-1; minimum and maximum absorption correction factors: 0.432 
and 0.717; 2θmax = 58.98º; 30565 collected reflections, 14370 unique (Rint = 0.0562); 
number of data/restraints/parameters 14370/0/662; final GOF 0.879; R1 = 0.0498 (9250 
reflections, I > 2σ(I)); wR2 = 0.1215 for all data; largest difference peak 2.168 e/Å3. 
When convergence is achieved residual density peaks higher than 1 e/Å3 are found close 
to the iridium atom. They have no chemical sense.  
Crystal data for 6.PF6: C36H38F6IrN6P·0.5(C4H10O), M = 928.95; orange prism, 0.265 
× 0.235 × 0.211 mm3, monoclinic, P21/c, a = 12.1243(9), b = 19.5765(15), c = 
15.7923(12) Å, β = 102.8500(10)º; Z =4; V = 3654.4(5) Å3; Dc = 1.688 g/cm3; µ = 3.767 
mm-1; minimum and maximum absorption correction factors: 0.407 and 0.528; 2θmax = 
56.82º; 42545 collected reflections, 8498 unique (Rint = 0.0239); number of 
data/restraints/parameters 8498/14/469; final GOF 1.052; R1 = 0.0233 (7514 
reflections, I > 2σ(I)); wR2 = 0.0569 for all data; largest difference peak 1.426 e/Å3.  
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